<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915041</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0390</org_study_id>
    <nct_id>NCT03915041</nct_id>
  </id_info>
  <brief_title>Effects of tDCS Combined With VR on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination</brief_title>
  <acronym>REVISTIM-XX</acronym>
  <official_title>Effects of tDCS Combined With Virtual Reality on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study proposes: to evaluate 1) whether the combination of virtual reality (VR) and&#xD;
      active tDCS provides better rumination attenuation than the combination of VR and tDCS&#xD;
      placebo 2) the acceptability and experiential experience of combining these two well known&#xD;
      medical devices.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion visit:&#xD;
&#xD;
        -  Confirmation of eligibility criteria&#xD;
&#xD;
        -  Written informed consent&#xD;
&#xD;
      Visit 1 and 2 (or end of study visit) :&#xD;
&#xD;
      Before first ruminations induction :&#xD;
&#xD;
        -  Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI),&#xD;
           Inventory, Visual Analogic Scale (VAS), Ruminative Response Scale - Short Form (RRS-SF),&#xD;
           Beck depression Inventory (BDI)&#xD;
&#xD;
        -  EEG recording&#xD;
&#xD;
      Then Procedure for inducing ruminations using a pre-recorded voice listened to in an audio&#xD;
      headset alternating statements promoting a positive, neutral and negative introspection and&#xD;
      self-judgment attitude (the latter are heard at the end to initiate the rumination process)&#xD;
      over 8 minutes&#xD;
&#xD;
      Then&#xD;
&#xD;
        -  Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale&#xD;
           (VAS), Beck depression Inventory (BDI),&#xD;
&#xD;
        -  EEG recording&#xD;
&#xD;
        -  Pulse and blood pressure measurements&#xD;
&#xD;
      Then immersion in a relaxing virtual environment for 20 minutes with active or sham placebo.&#xD;
&#xD;
      â€¢ Cutaneous conductance measurement and eye-tracking during immersion&#xD;
&#xD;
      At the end of immersion :&#xD;
&#xD;
        -  Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale&#xD;
           (VAS), Beck depression Inventory (BDI), IGroup presence questionnaire (IPQ)&#xD;
&#xD;
        -  Pulse and blood pressure measurements&#xD;
&#xD;
      Then again procedure for inducing ruminations .&#xD;
&#xD;
      At the end of ruminations induction :&#xD;
&#xD;
        -  Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI),&#xD;
           Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), tolerance&#xD;
           questionnaires&#xD;
&#xD;
        -  Debriefing&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Actual">August 14, 2020</completion_date>
  <primary_completion_date type="Actual">August 14, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in anxious ruminations after anodal tDCS and virtual reality</measure>
    <time_frame>within 1 week</time_frame>
    <description>Change in anxious ruminations after anodal tDCS and virtual reality will be evaluated to compare the effects of tDCS associated with virtual reality versus virtual reality alone (+ tDCS placebo) to reduce ruminations.&#xD;
Evaluate with Brief State Ruminative Inventory (BSRI). It is a scale with 8 items. Each item is VAS with a score ranging between 0 and 100. The total score is sum of each item score (Total /800)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Rumination</condition>
  <arm_group>
    <arm_group_label>VR + active brain stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exposure to a virtual reality world with active transcranial electric stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VR + sham brain stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Exposure to a virtual reality world with sham transcranial electric stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VR + active brain stimulation</intervention_name>
    <description>Active Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)</description>
    <arm_group_label>VR + active brain stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VR +sham brain stimulation</intervention_name>
    <description>Sham Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)</description>
    <arm_group_label>VR + sham brain stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Without any particular ethnic and psychosocial criteria&#xD;
&#xD;
          -  Subject to ruminations (personality trait) documented by a RRS-SF score &gt;30&#xD;
&#xD;
          -  Subjects with score to BDI scal &lt;14 assessed during first visit&#xD;
&#xD;
          -  Subjects without psychiatric or addictive disorders.&#xD;
&#xD;
          -  Subjects who do not meet all the diagnostic criteria for an anxiety disorder or&#xD;
             characterized depressive episode.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindication to tDCS (neurosurgical history, intracranial device, skin problems)&#xD;
&#xD;
          -  current virtual reality intolerance&#xD;
&#xD;
          -  history of psychiatric or addictive disorders&#xD;
&#xD;
          -  Use of psychotropic drugs&#xD;
&#xD;
          -  Use of non psychotropic treatments significantly influencing mood or level of anxiety&#xD;
&#xD;
          -  pregnant or breast-feeding women&#xD;
&#xD;
          -  Neurological pathology, locomotor disability, or sensory (vestibular, visual, auditory&#xD;
             ...)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>virtual reality</keyword>
  <keyword>brain stimulation</keyword>
  <keyword>tDCS</keyword>
  <keyword>phenomenology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rumination Syndrome</mesh_term>
    <mesh_term>Feeding and Eating Disorders of Childhood</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

